Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes

被引：0
|
作者：
Hong-wei Gao
Chao Xie
Hai-ning Wang
Yu-jing Lin
Tian-pei Hong
机构：
[1] Peking University Third Hospital,Department of Endocrinology
来源：
Acta Pharmacologica Sinica | 2007年 / 28卷
关键词：
nateglinide; acarbose; free fatty acids; asymmetric dimethylarginine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：534 / 539
页数：5
相关论文
共 50 条
  • [41] Subclinical diastolic dysfunction in newly-diagnosed type 2 diabetes: Prevalence and risk factors
    Kazlauskaite, Rasa
    Kelly, Russell F.
    Evans, Arthur
    Doukky, Rami
    Mehta, Avinder
    Han, Jianping
    Quadri, Syed F.
    Boral, Leonard
    Mascarell, Susana
    Holt, Geraldine
    Fogelfeld, Leon A.
    DIABETES, 2006, 55 : A158 - A158
  • [42] Main determinants of autonomic dysfunction in subjects with normoglycaemia and newly-diagnosed type 2 diabetes
    Dimova, R.
    Tankova, T.
    Chakarova, N.
    Dakovska, L.
    Grozeva, G.
    DIABETOLOGIA, 2015, 58 : S508 - S508
  • [43] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
    Zirui Hao
    Yue Sun
    Guiping Li
    Yuli Shen
    Yingzhen Wen
    Yan Liu
    BMC Endocrine Disorders, 22
  • [44] Effects of diet, glibenclamide and voglibose on visceral adiposity and insulin resistance in newly-diagnosed type 2 diabetes mellitus
    Takami, K
    Takeda, N
    Sasaki, A
    Hattori, J
    Takami, R
    Yoshino, K
    Sugimoto, M
    Nakashima, K
    Okumura, S
    Koseki, S
    Matsui, M
    Hayashi, M
    Yasuda, K
    DIABETES, 1998, 47 : A92 - A92
  • [45] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
    Hao, Zirui
    Sun, Yue
    Li, Guiping
    Shen, Yuli
    Wen, Yingzhen
    Liu, Yan
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [46] Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia
    Ramirez-Morros, Anna
    Franch-Nadal, Josep
    Real, Jordi
    Miro-Catalina, Queralt
    Bundo, Magdalena
    Vlacho, Bogdan
    Mauricio, Didac
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [47] Effects of the Alpha Glucosidase inhibitor Acarbose on Endothelial Function after a Mixed Meal in Newly Diagnosed Type 2 Diabetes
    Pistrosch, F.
    Schaper, F.
    Passauer, J.
    Koehler, C.
    Bornstein, S. R.
    Hanefeld, M.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (02) : 104 - 108
  • [48] Effects of insulin therapy on glucagon in patients with newly diagnosed type 2 diabetes
    He, Yuanyuan
    Wu, Bo
    Meng, Mei
    Ma, Weiqing
    Zhu, Defa
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (04): : 1832 - 1839
  • [49] Metformin induced changes in gut microbiome composition in healthy individuals and newly-diagnosed type 2 diabetes patients
    Elbere, I.
    Kalnina, I.
    Silamikelis, I.
    Dindune, I. I.
    Gulbinska, L.
    Zaharenko, L.
    Radovica-Spalvina, I.
    Gudra, D.
    Fridmanis, D.
    Konrade, I.
    Pirags, V.
    Klovins, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 85 - 86
  • [50] Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes
    Chen, Lu-Lu
    Yu, Fan
    Zeng, Tian-shu
    Liao, Yun-fei
    Li, Yu-ming
    Ding, Hong-cheng
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 296 - 301
12345